Arteriovenous Fistula Creation and Estimated Glomerular Filtration Rate Decline in Advanced CKD: A Matched Cohort Study

Background Kidney failure is associated with ahigh burden of morbidity and mortality. Previous studies have raised the possibility that arteriovenous fi stula (AVF) creation may attenuate eGFR decline. This study aimed to compare eGFR decline in predialysis patients with an AVF, matched to patients oriented toward peritoneal dialysis (PD). Methods Predialysis patients with an AVF and those oriented toward PD were retrospectively matched using a propensity score. Time zero was de fi ned as the “ AVF creation date ” for the AVF group and the “ date when eGFR was closest to the matched patient ’ s eGFR at AVF creation ” for the PD group. Crude and predicted eGFR decline in AVF and PD groups were compared before and after time zero using mixed-effect linear regressions. Results In total, 61 pairs were matched. Crude annual eGFR decline before AVF creation/time zero was 2 4.1 ml/ min per m 2 per year in the AVF group versus 2 5.3 ml/min per m 2 per year in the PD group ( P 5 0.75) and after time zero, 2 2.5 ml/min per m 2 per year in the AVF group versus 2 4.5 ml/min per m 2 per year in the PD group ( P 5 0.02). The predicted annual decline decreased from 2 5.1 ml/min per m 2 per year in the AVF group before AVF creation to 2 2.8 ml/min per m 2 per year after ( P , 0.01), whereas there was no difference in the PD group ( 2 5.5 versus 2 5.1 ml/min per m 2 per year respectively, P 5 0.41). Conclusions In this matched study, AVF creation was associated with a deceleration of kidney function decline compared with a control PD-oriented group. Prospective studies are needed to assess the potential mechanisms between vascular access creation and eGFR slope attenuation. KIDNEY360

[1]  B. Astor,et al.  KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  L. Laurin,et al.  Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients , 2019, BMC Nephrology.

[3]  J. Carrero,et al.  Arteriovenous access placement and renal function decline. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  J. Sharman,et al.  Determinants of increased central excess pressure in dialysis: role of dialysis modality and arteriovenous fistula. , 2019, American journal of hypertension.

[5]  M. Böhm,et al.  Effects of Arteriovenous Fistula on Blood Pressure in Patients With End‐Stage Renal Disease: A Systematic Meta‐Analysis , 2019, Journal of the American Heart Association.

[6]  Douglas E Schaubel,et al.  US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  E. Hamoir,et al.  The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  V. Melenovský,et al.  Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease , 2016, Hypertension Research.

[9]  T. Golper,et al.  Arteriovenous fistula creation may slow estimated glomerular filtration rate trajectory. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  F. Locatelli,et al.  Arteriovenous fistula as a nephroprotective intervention in advanced CKD: scientific discovery and explanation, and the evaluation of interventions. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  J. Pepper,et al.  Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. , 2015, The New England journal of medicine.

[12]  J. Kellum,et al.  Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. , 2015, JAMA.

[13]  Abdulrhman Aldukhayel Prevalence of Depressive Symptoms among Hemodialysis and Peritoneal Dialysis Patients. , 2015, International journal of health sciences.

[14]  Harold I Feldman,et al.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  R. Fluck,et al.  Creation of an Arteriovenous Fistula Is Associated with Significant Acute Local and Systemic Changes in Microvascular Function , 2013, Nephron Clinical Practice.

[16]  R. Foley,et al.  The USRDS: what you need to know about what it can and can't tell us about ESRD. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[17]  F. Lucas,et al.  Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. , 2011, Kidney international.

[18]  R. Fluck,et al.  Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  P. Klemmer,et al.  High‐output heart failure secondary to arteriovenous fistula , 2011, Hemodialysis international. International Symposium on Home Hemodialysis.

[20]  F. Floccari,et al.  Right Ventricular Diastolic Function in Dialysis Patients Could Be Affected by Vascular Access , 2010, Nephron Clinical Practice.

[21]  M. Lebel,et al.  The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  O. Djurdjev,et al.  Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  J. Kaufman,et al.  Age affects outcomes in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.

[24]  M. Yigla,et al.  Pulmonary Hypertension in Hemodialysis Patients: An Unrecognized Threat , 2006, Seminars in dialysis.

[25]  R. Atkins,et al.  Vascular access and all-cause mortality: a propensity score analysis. , 2004, Journal of the American Society of Nephrology : JASN.

[26]  T. Weinstein,et al.  The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  E W Young,et al.  Type of vascular access and mortality in U.S. hemodialysis patients. , 2001, Kidney international.

[28]  N. Powe,et al.  Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  J. Kooman,et al.  Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  E. Krieger,et al.  Cardiac Effects of Persistent Hemodialysis Arteriovenous Access in Recipients of Renal Allograft , 2000, Cardiology.

[31]  M. Wiedemann,et al.  Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  K H Wesseling,et al.  Effects of arteriovenous fistulas on cardiac oxygen supply and demand. , 1999, Kidney international.

[33]  N. Powe,et al.  Septicemia in dialysis patients: incidence, risk factors, and prognosis. , 1999, Kidney international.

[34]  A. Torres,et al.  Subclavian vascular access stenosis in dialysis patients: natural history and risk factors. , 1998, Journal of the American Society of Nephrology : JASN.

[35]  D. Churchill,et al.  Canadian Hemodialysis Morbidity Study. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  J. Bragg-Gresham,et al.  US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  C. Wanner,et al.  Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  J. Małyszko,et al.  To close or not to close: fistula ligation and cardiac function in kidney allograft recipients. , 2012, Polskie Archiwum Medycyny Wewnetrznej.

[39]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .

[40]  B. Gersh Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2011 .

[41]  J. Berns,et al.  KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  J. Himmelfarb Hemodialysis complications. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.